Find Federal Grants
Centers for Disease Control and Prevention - ERA · RFA-GH-20-005
Strengthening Civil Society Organizations' Capacity and Coordination for Accelerated HIV Epidemic Control in Uganda through Supporting Implementation of Comprehensive HIV/AIDS Prevention and Treatment for Key Populations (KP) under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2068
Strengthening the Government of Uganda's Capacity for Regionally Centered and District Implemented HIV and TB Programming through Health Information Systems, Case Based Surveillance, Monitoring, Evaluation and Quality Improvement Support under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2066
Engagement of FBOs and CBOs/PNFPs to Support and Sustain HIV Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2069
Building Capacity within the Government of Tanzania to Oversee Laboratory, Strengthen Scientific Oversight, Monitor Evidence-based HIV Interventions, and Conduct Geo-spatial Analysis under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2064
Digital, Limited Interaction Trials and Epidemiology (D-LITE): Targeting HIV Incidence in the United States (U01 Clinical Trial Required)
National Institutes of Health · RFA-AI-19-067
National Institutes of Health · RFA-OD-20-002
National Institutes of Health · PAR-20-085
Accelerating and Sustaining HIV Epidemic Control and Related Diseases in Western and West-Nile Regions in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2065
Achieving Undetectable=Untransmittable in India through Quality Laboratory Testing, Workforce Development, Improved Result Utilization, and Strong Laboratory Epidemiology Platforms for Informed Public Health Response under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2037
Accelerating Lesotho's Progress to Epidemic Control Through Health System Strengthening and Delivery of Comprehensive HIV/TB Care, Treatment and Prevention Services under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2045
Enhancing the Government of India's Capacity through Technical Assistance to India's National AIDS Control Organization (NACO) to Strengthen the Prevention to Treatment Cascade for People Living with HIV, Including Key Populations, under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2038
Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2059
Expanding Access to Quality Laboratory Service (EQUALS) in the Kingdom of Lesotho under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2044
Namibia Project for Information System Strengthening, Continuous Quality Improvement and Enhanced Surveillance to Sustain Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2060
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
National Institutes of Health · PAR-20-038
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-20-037
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
National Institutes of Health · PAR-20-084
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
National Institutes of Health · PA-20-025
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
National Institutes of Health · PA-20-047